Don’t miss this PCR Tokyo Valves 2025 session replay, where experts dive into the clinical benefits of the Mini 4D TEE Probe in TAVR and LAAC procedures. Learn how this miniaturised probe enhances patient outcomes in TAVR, contributing to more efficient procedures and improved safety. Discover...

Delve into the challenges and innovations in tricuspid and pulmonary valve interventions. Discover cases involving imaging nightmares for treating severe tricuspid regurgitation, transcatheter pulmonary valve implantation for heavily calcified lesions, and the use of the "zipping technique" for massive tricuspid valve flail gaps. Explore the strategies...

Delve into the latest TAVI-related research and advancements. Explore studies on optimizing hemostasis during TAVI, the safety and efficacy of TAVI in Filipino patients, the outcomes of TAVI in hemodialysis patients, and the effectiveness of patient education videos for TAVI. Stay up-to-date with the latest developments...

This session offers valuable insights into various aspects of left atrial appendage (LAA) closure, a critical procedure for stroke prevention in atrial fibrillation patients. Explore improvements to the safety checklist, case studies on left atrial thrombosis and mobile thrombus management, as well as a successful case...

Struggling with PCI after TAVI? This session breaks it down with 3 real-world cases. You'll learn when and how to perform revascularization in severe AS patients, the impact of commissure alignment on future coronary access, and expert techniques for post-TAVI PCI:

• Case 1: Managing a patient with...

Should you intervene earlier in patients with moderate aortic stenosis and heart failure? This session breaks down the latest trials shaping clinical decisions.

You'll get the key takeaways from EARLY TAVR, EVOLVED, TAVR UNLOAD, PROGRESS and EXPAND TAVR II (what they reveal, what they don’t and how...

This comprehensive session delves into the 'burning issues' in TAVI, covering a wide range of topics. Discover the impact of catheter insertion on left ventricular pacing, the importance of the en-face view for coronary cannulation, comparisons of TAVI valve expansions, indications for left and right ventricular...

In 2002, Alain Cribier revolutionised the field by introducing transcatheter aortic valve implantation (TAVI) as a complementary technique to surgery. Find out more about his early life and studies.

Aortic stenosis (AS) is the most common valvular heart disease leading to intervention. It is characterized by progression from leaflet thickening and calcification to significant haemodynamic stenosis which results in disease-specific symptoms and physical limitations as well as poor prognosis and impaired quality of life if...

The transformation in the field of interventional cardiology is unprecedented. Today, interventional cardiology encompasses an ever-growing list of diagnostic and therapeutic percutaneous procedures performed in the cathlab.

It is with great sadness that PCR and the interventional cardiology community learnt of the death of Professor Alain Cribier, pioneer in the non-invasive treatment of valvular disease, superb doctor and professor of medicine and great humanist whose concern and care for his patients went beyond...

Salvatore Brugaletta is an Interventional Cardiologist at the “Hospital Clínic de Barcelona”, Spain and associate professor of Medicine at the University of Barcelona. Highly skilled in Clinical Research, Medical Education and Medical Devices with strong commitment inside medical communities, he received two PhD degrees focused on interventional cardiology from Erasmus University (Rotterdam,...

Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.

Lucas Lauder and Felix Mahfoud provide a summary of the ESC Guidelines on elevated blood pressure and hypertension presented by John William McEvoy and Rhian Touyz at ESC Congress 2024 in London.

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.